Lv31
228 积分 2024-11-05 加入
Target identification and assessment in the era of AI
1小时前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
1个月前
已完结
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets
3个月前
已完结
TargetPair: A Single Cell-omics Resource of Clinical Trials-derived Therapeutical Target Combinations for Cancer Therapy
5个月前
已关闭
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
5个月前
已完结
Model-Informed Immunogenicity Assessment of Nivolumab as Monotherapy and in Combination with Ipilimumab
6个月前
已完结
Hallmarks of artificial intelligence contributions to precision oncology
8个月前
已完结
Development of Cancer Drug Targets and Potential Anti-Cancer Agents using Deep Learning and Screening Processes
8个月前
已关闭
C2H2-zinc-finger transcription factors bind RNA and function in diverse post-transcriptional regulatory processes
9个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
9个月前
已完结
皖公网安备34019202002308
